Oncology: Prostate Cancer 2/11/14
What works and what doesn't in prostate cancer? (video)
Over the past few years, genitourinary oncologists have acquired multiple therapeutic tools to attack prostate cancer from different directions to improve survival and have honed the use of PSA testing to avoid overtreatment, according to three authorities in the field: H. Ballentine Carter, MD, of Johns Hopkins University,Howard I. Scher, MD, of Memorial Sloan-Kettering Cancer Center in New York City, and Eric Klein, MD, of the Cleveland Clinic. Disappointments include the inability to find a cure for castration-resistant prostate cancer.